Literature DB >> 7952860

Effects of GABA and various allosteric ligands on TBPS binding to cloned rat GABA(A) receptor subtypes.

W B Im1, J F Pregenzer, D R Thomsen.   

Abstract

1. [35S]t-butylbicyclophosphorothionate (TBPS) is a high affinity ligand for the picrotoxin site of GABA(A) receptors. Here we examined TBPS binding to the cloned receptors made of alpha 1, alpha 3 or alpha 6 in combination with beta 2 or beta 2 and gamma 2 subunits, in the presence of GABA and several allosteric ligands (diazepam, methyl 6,7-dimethoxy-4-methyl-beta-carboline-3-carboxylate (DMCM), 3 alpha,21-dihydroxy-5 alpha-pregnan-20-one (5 alpha-THDOC), pentobarbitone and Zn). The cloned receptors were transiently expressed in SF-9 insect cells by infecting with recombinant baculoviruses. 2. In alpha beta subtypes, GABA at nanomolar concentrations enhanced TBPS binding but inhibited binding at micromolar concentrations. Half maximal GABA concentrations for enhancement or inhibition of TBPS binding were correlated with high and low affinity GABA binding sites, respectively, in individual subtypes. The maximal enhancement of binding also varied according to the alpha isoform (alpha 3 beta 2 >> alpha 1 beta 2). In alpha beta gamma subtypes, TBPS binding was unaffected by GABA at nanomolar concentrations, but was inhibited by GABA at micromolar concentrations. Addition of gamma 2 thus appeared to abolish conformational coupling between high affinity GABA sites and TBPS sites, and also altered low affinity GABA sites; in particular, the half maximal GABA concentration for inhibition of TBPS binding changed from > 100 (alpha 6 beta 2) to 1 microM (alpha 6 beta 2 gamma 2). 3. Allosteric ligands also altered TBPS binding to sensitive GABA(A) receptor subtypes. For instance,diazepam only in the alpha 1 beta2 gamma 2 and alpha 3 beta 2 gamma 2 subtypes, and 5 alpha-THDOC in all the subtypes enhanced TBPS binding in the absence of GABA, and intensified the inhibitory effect of GABA. Pentobarbitone exhibited only the latter effect in all the subtypes we examined.4. DMCM and Zn, inhibitors of GABA-induced Cl currents in alpha beta gamma and alpha beta subtypes, respectively,produced opposite effects to agonists, decreasing TBPS binding in the absence of GABA and attenuating(or eliminating in the case of Zn) the inhibitory effect of GABA on TBPS binding.5. These results show that GABA binding sites and their conformational coupling with TBPS sites are differentially affected by the alpha isoform (particularly alpha 6 as compared to alpha l or alpha 3) and by quaternary interactions involving the gamma 2 subunit. Moreover, changes in TBPS binding by allosteric ligands include not only direct (allosteric) effects on TBPS sites but also indirect effects via GABA sites, and are consistent with their known subtype selectivity and functionality from previous studies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7952860      PMCID: PMC1910256          DOI: 10.1111/j.1476-5381.1994.tb13185.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  Type I and type II GABAA-benzodiazepine receptors produced in transfected cells.

Authors:  D B Pritchett; H Lüddens; P H Seeburg
Journal:  Science       Date:  1989-09-22       Impact factor: 47.728

2.  The effect of subunit composition of rat brain GABAA receptors on channel function.

Authors:  E Sigel; R Baur; G Trube; H Möhler; P Malherbe
Journal:  Neuron       Date:  1990-11       Impact factor: 17.173

Review 3.  The GABAA receptor: molecular biology reveals a complex picture.

Authors:  P R Schofield
Journal:  Trends Pharmacol Sci       Date:  1989-12       Impact factor: 14.819

4.  Functional properties of recombinant rat GABAA receptors depend upon subunit composition.

Authors:  T A Verdoorn; A Draguhn; S Ymer; P H Seeburg; B Sakmann
Journal:  Neuron       Date:  1990-06       Impact factor: 17.173

5.  Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology.

Authors:  D B Pritchett; H Sontheimer; B D Shivers; S Ymer; H Kettenmann; P R Schofield; P H Seeburg
Journal:  Nature       Date:  1989-04-13       Impact factor: 49.962

Review 6.  Molecular biology of GABAA receptors.

Authors:  R W Olsen; A J Tobin
Journal:  FASEB J       Date:  1990-03       Impact factor: 5.191

7.  Structural and functional basis for GABAA receptor heterogeneity.

Authors:  E S Levitan; P R Schofield; D R Burt; L M Rhee; W Wisden; M Köhler; N Fujita; H F Rodriguez; A Stephenson; M G Darlison
Journal:  Nature       Date:  1988-09-01       Impact factor: 49.962

8.  Cerebellar GABAA receptor selective for a behavioural alcohol antagonist.

Authors:  H Lüddens; D B Pritchett; M Köhler; I Killisch; K Keinänen; H Monyer; R Sprengel; P H Seeburg
Journal:  Nature       Date:  1990-08-16       Impact factor: 49.962

9.  Two novel GABAA receptor subunits exist in distinct neuronal subpopulations.

Authors:  B D Shivers; I Killisch; R Sprengel; H Sontheimer; M Köhler; P R Schofield; P H Seeburg
Journal:  Neuron       Date:  1989-09       Impact factor: 17.173

10.  A novel alpha subunit in rat brain GABAA receptors.

Authors:  M Khrestchatisky; A J MacLennan; M Y Chiang; W T Xu; M B Jackson; N Brecha; C Sternini; R W Olsen; A J Tobin
Journal:  Neuron       Date:  1989-12       Impact factor: 17.173

View more
  7 in total

1.  Biphasic modulation of GABA(A) receptor binding by steroids suggests functional correlates.

Authors:  S Srinivasan; D W Sapp; A J Tobin; R W Olsen
Journal:  Neurochem Res       Date:  1999-11       Impact factor: 3.996

2.  Influences on blockade by t-butylbicyclo-phosphoro-thionate of GABA(A) receptor spontaneous gating, agonist activation and desensitization.

Authors:  Nidaa A Othman; Michael Gallacher; Tarek Z Deeb; Daniel T Baptista-Hon; David C Perry; Tim G Hales
Journal:  J Physiol       Date:  2011-11-14       Impact factor: 5.182

3.  Characterization of [35S]t-butylbicyclophosphorothionate ([35S]TBPS) binding to GABAA receptors in postmortem human brain.

Authors:  J R Atack; Y Ohashi; R M McKernan
Journal:  Br J Pharmacol       Date:  2007-03-05       Impact factor: 8.739

4.  Development of Inhaled GABAA Receptor Modulators to Improve Airway Function in Bronchoconstrictive Disorders.

Authors:  Nicolas M Zahn; M S Rashid Roni; Gene T Yocum; Michelle J Meyer; Daniel A Webb; Md Yeunus Mian; James M Cook; Douglas C Stafford; Charles W Emala; Leggy A Arnold
Journal:  ACS Pharmacol Transl Sci       Date:  2022-02-01

5.  Comparative pharmacodynamic and pharmacokinetic study of MIDD0301 and its (S) enantiomer.

Authors:  M S Rashid Roni; Nicolas M Zahn; Gene T Yocum; Daniel A Webb; Md Yeunus Mian; Michelle J Meyer; Anika S Tylek; James M Cook; Charles W Emala; Douglas C Stafford; Leggy A Arnold
Journal:  Drug Dev Res       Date:  2022-03-04       Impact factor: 5.004

6.  Age-related GABAA receptor changes in rat auditory cortex.

Authors:  Donald M Caspary; Larry F Hughes; Lynne L Ling
Journal:  Neurobiol Aging       Date:  2012-12-17       Impact factor: 4.673

7.  A Structure-Activity Relationship Comparison of Imidazodiazepines Binding at Kappa, Mu, and Delta Opioid Receptors and the GABAA Receptor.

Authors:  Guanguan Li; Amanda N Nieman; Md Yeunus Mian; Nicolas M Zahn; Brandon N Mikulsky; Michael M Poe; Kashi R Methuku; Yongfeng Liu; James M Cook; Douglas C Stafford; Leggy A Arnold
Journal:  Molecules       Date:  2020-08-25       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.